Get started
Author

Tetsuya Nakatsura

Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma
2014 · Tetsuya Nakatsura, Kazuya Ofuji, et al. · Journal of Hepatocellular Carcinoma · 29
PDF
Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy
2024 · Arnaud Couzinet, Toshihiro Suzuki, et al. · Expert Opinion on Therapeutic Targets · 28
Identification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from the lung carcinoma antigen, Lengsin
2011 · Tetsuya Nakatsura · International Journal of Oncology · 12
PDF
Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr)
2025 · Chikako Funasaka, Yoichi Naito, et al. · Frontiers in Oncology · 5
PDF
Abstract 3552: Personalized neoantigen cancer vaccine assembled on DC targeting antibody improves cancer immunity
2022 · Yuji Mishima, Fumiko Isoda, et al. · Cancer Research · 1
Corrigendum to “Longitudinal monitoring of cellular immunity by the ex vivo activation of genes in leukocytes (EAGL) assay highlights potential markers of mRNA COVID-19 vaccine efficacy against breakthrough symptoms” [Vaccine 68 (2025) 127942]
2026 · Taro Saito, Arnaud Couzinet, et al. · Vaccine
Abstract 6389: A novel computational pipeline supported with in vivo vaccination models for identification and validation of neoantigens
2022 · Kazushi Hiranuka, Keigo Takahashi, et al. · Cancer Research
SiRNA
2014 · Tetsuya Nakatsura · Springer eBooks
SiRNA
2014 · Tetsuya Nakatsura · Springer eBooks
SiRNA
2011 · Tetsuya Nakatsura · Springer eBooks
Works count: 10
Citation count: 75
H-index: 4
I10-index: 3
Year
Topic
Type